Related Experiment Video
Updated: Mar 27, 2026

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
Published on: July 27, 2022
From Liquid to Solid: Formulation and Characterization of Testosterone-Loaded S-SMEDDS Pellets Using a 24 Factorial
Ohary de Sousa Borges1, Julia Ornelas Kramer1, Henrique Pascoa1
1Center for R&D and Innovation in Pharmaceutical Technology and Nanomedicine, Federal University of Goiás, Goiânia, GO, Brazil.
Solid self-microemulsifying drug delivery systems (SMEDDS) offer a viable path for industrial production. This study successfully developed solid testosterone-loaded SMEDDS pellets using extrusion-spheronization, demonstrating good formulation stability and redispersibility.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Materials Science
Background:
- Self-microemulsifying drug delivery systems (SMEDDS) present challenges in industrial-scale production due to their liquid nature.
- Solid dosage forms are preferred for improved handling, stability, and patient compliance.
Purpose of the Study:
- To develop a solid self-microemulsifying drug delivery system (S-SMEDDS) of testosterone (TST).
- To convert liquid SMEDDS into a stable, solid dosage form using extrusion-spheronization.
- To optimize TST/S-SMEDDS pellet formulation parameters via a 2^4 full factorial design.
Main Methods:
- Extrusion-spheronization technique for pellet formation.
- Characterization of pellets: particle size distribution, sphericity, flow properties, disintegration, and redispersibility.
- Compatibility studies using Thermogravimetric Analysis (TG/DSC) and Fourier Transform Infrared Spectroscopy (FT-FTIR).
Main Results:
- No incompatibility observed between testosterone, SMEDDS components, and pellet excipients.
- Reconstituted SMEDDS maintained optimal droplet size (170-190 nm) and Polydispersity Index (PDI) (0.2-0.3).
- Achieved testosterone concentrations of 30.8 μg/g (F1), 20.2 μg/g (F16), and 21.1 μg/g (F19) per pellet.
Conclusions:
- Solidification of SMEDDS via extrusion-spheronization is a feasible method for industrial-scale testosterone delivery.
- The developed TST/S-SMEDDS pellets exhibit favorable physicochemical properties and formulation stability.
- This approach facilitates the transition of SMEDDS technology to robust solid dosage forms.
More Related Videos
Related Concept Videos
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Modified-Release Drug Delivery Systems: Site-Targeted
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Modified-Release Drug Delivery Systems: Influencing Factors
Modified-Release Drug Delivery Systems: Rate-Programmed II

